Wish the gluten-free diet wasn’t the only protection against your celiac disease?
The CeliacShield Study is being conducted to assess the investigational drug latiglutenase and its ability to protect the small intestine of celiac disease patients from gluten exposure.
- 18-80 years old
- Confirmed diagnosis of celiac disease
- On gluten-free diet for the last 12 months
- Willing to take gluten with daily evening meal for 6 weeks
- Able to attend study visits in Rochester, MN
Compensation and reimbursement for eligible travel provided.